| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.062 | 0.3 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.3 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |